H.R. 3536 — To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.

Summary

This bill prohibits federal agencies and nonprofit entities that conduct federally funded health care research from providing a patent for a drug based on such research until the entity receiving the patent enters into a reasonable pricing agreement with the Department of Health and Human Services.

Full Text

Related Legislation

S. 1681A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.
2017-07-31Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related

Legislative Actions

2017-07-28
Introduced in House
2017-07-28
Introduced in House
2017-07-28
Referred to the House Committee on Energy and Commerce.
2017-08-04
Referred to the Subcommittee on Health.

To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.

Sponsors

Subjects

Summary

Full Text

Related Legislation

Legislative Actions

Ask about this bill